{
    "clinical_study": {
        "@rank": "131122", 
        "arm_group": {
            "arm_group_label": "neutropenic patients", 
            "arm_group_type": "Other"
        }, 
        "brief_summary": {
            "textblock": "The aim of the present work is to study the protein expressions profiles of neutropenic\n      patients (with a high risk of invasive mycosis) who developed - versus who did not develop\n      invasive mycosis (principally aspergillosis and candidosis) in order to identify biomarkers\n      for the diagnosis, prognosis and /or prediction of invasive mycosis."
        }, 
        "brief_title": "Identification of Serum and/or Plasma Biomarkers for the Diagnosis Prognosis and/or Prediction of Invasive Mycosis in Neutropenic Patients", 
        "completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "condition": "Neutropenic Patients", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  - Patients with malignant haemopathy who received chemotherapy likely to lead to\n             severe neutropenia (PN<500/mm3) for a foreseeable period of 10 days.\n\n          -  Patients aged 14 years or older (no upper age limit)\n\n          -  Patients with malignant haemopathy who received an autologous marrow graft.\n\n          -  Patients with severe idiopathic medullar aplasia (PN<500/mm3) who need to be\n             hospitalised for at least 10 days consecutively (with or without immunosuppressant\n             treatment).\n\n          -  Patients who have provided written informed consent to participate in this study.\n\n        Exclusion Criteria:\n\n          -  Patients who received an allograft of marrow or hematopoietic stem cell transplant\n             (given that these patients carry a risk of aspergillosis, which in most cases appears\n             after medullar recovery, they will not be included in the study).\n\n          -  Patients who received an autologous hematopoietic stem cell transplant (given that\n             the duration of the neutropenia is often less than 10 days).\n\n          -  Patients who do not meet the inclusion criteria\n\n          -  Persons not covered by the national Health Insurance Agency"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "14 Years"
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01907477", 
            "org_study_id": "Dalle PHRC IR 2009"
        }, 
        "intervention": {
            "arm_group_label": "neutropenic patients", 
            "intervention_name": "Samples taken at the clinical hematology unit", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 22, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Dijon", 
                    "country": "France", 
                    "zip": "21079"
                }, 
                "name": "CHU de Dijon"
            }
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "the variability of protein profiles", 
            "safety_issue": "No", 
            "time_frame": "baseline"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01907477"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Centre Hospitalier Universitaire Dijon", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire Dijon", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2008", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}